biote Corp. (BTMD)
1.07
-0.02
(-1.83%)
USD |
NASDAQ |
Oct 23, 16:00
1.06
-0.01
(-0.93%)
After-Hours: 20:00
biote Net Income (Quarterly) : -7.428M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.428M |
| March 31, 2026 | 2.676M |
| December 31, 2025 | 2.617M |
| September 30, 2025 | 9.216M |
| June 30, 2025 | 3.925M |
| March 31, 2025 | 15.84M |
| December 31, 2024 | 3.483M |
| September 30, 2024 | 12.66M |
| June 30, 2024 | -10.37M |
| March 31, 2024 | -5.726M |
| December 31, 2023 | 12.08M |
| Date | Value |
|---|---|
| September 30, 2023 | 19.64M |
| June 30, 2023 | -13.10M |
| March 31, 2023 | -21.43M |
| December 31, 2022 | 12.81M |
| September 30, 2022 | 0.494M |
| June 30, 2022 | -21.33M |
| March 31, 2022 | 7.477M |
| December 31, 2021 | -1.178M |
| September 30, 2021 | 8.537M |
| June 30, 2021 | 9.761M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cannabis Strategic Ventures, Inc. | -0.0066M |
| Rafael Holdings, Inc. | -2.898M |
| Concentra Group Holdings Parent, Inc. | 65.93M |
| Elite Health Systems, Inc. | -1.532M |
| U.S. Stem Cell, Inc. | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 44.23M |
| Total Expenses (Quarterly) | 50.80M |
| EPS Diluted (Quarterly) | -0.2293 |
| Enterprise Value | 154.67M |
| Gross Profit Margin (Quarterly) | 63.69% |
| Profit Margin (Quarterly) | -16.79% |
| Earnings Yield | 11.25% |
| Operating Earnings Yield | 62.48% |
| Normalized Earnings Yield | 18.64 |